Patient outcomes of non-small-cell lung cancer (NSCLC) vary because of tumor heterogeneity and treatment strategies. This study aimed to construct a deep learning model combining both radiomic and clinical features to predict the overall survival of patients with NSCLC. To improve the reliability of the proposed model, radiomic analysis complying with the Image Biomarker Standardization Initiative and the compensation approach to integrate multicenter datasets were performed on contrast-enhanced computed tomography (CECT) images. Pretreatment CECT images and the clinical data of 492 patients with NSCLC from two hospitals were collected. The deep neural network architecture, DeepSurv, with the input of radiomic and clinical features was employed. The performance of survival prediction model was assessed using the C-index and area under the curve (AUC) 8, 12, and 24 months after diagnosis. The performance of survival prediction that combined eight radiomic features and five clinical features outperformed that solely based on radiomic or clinical features. The C-index values of the combined model achieved 0.74, 0.75, and 0.75, respectively, and AUC values of 0.76, 0.74, and 0.73, respectively, 8, 12, and 24 months after diagnosis. In conclusion, combining the traits of pretreatment CECT images, lesion characteristics, and treatment strategies could effectively predict the survival of patients with NSCLC using a deep learning model.

Background: Predicting malignancy in small lung nodules (SLNs) across diverse populations is challenging due to significant demographic and clinical variations. This study investigates whether transfer learning (TL) can improve malignancy prediction for SLNs using low-dose computed tomography across datasets from different countries. Methods: We collected two datasets: an Asian dataset (669 SLNs from Cathay General Hospital, CGH, Taiwan) and an American dataset (600 SLNs from the National Lung Screening Trial, NLST, America). Initial U-Net models for malignancy prediction were trained on each dataset, followed by the application of TL to transfer model parameters across datasets. Model performance was evaluated using accuracy, specificity, sensitivity, and the area under the receiver operating characteristic curve (AUC). Results: Significant demographic differences (p < 0.001) were observed between the CGH and NLST datasets. Initial models trained on one dataset showed a substantial performance decline of 15.2% to 97.9% when applied to the other dataset. TL enhanced model performance across datasets by 21.1% to 159.5% (p < 0.001), achieving an accuracy of 0.86–0.91, sensitivity of 0.81–0.96, specificity of 0.89–0.92, and an AUC of 0.90–0.97. Conclusions: TL enhances SLN malignancy prediction models by addressing population variations and enabling their application across diverse international datasets.